Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer
Craig M. Goodwin(Vanderbilt University), Stephen W. Fesik(Vanderbilt University)
Cited by 107
Related Papers
Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer
|Cancer Research|2022|156
Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core
|Journal of Medicinal Chemistry|2019|63